PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GTCbio Announces Biomarker Summit 2012 - March 15-16 in San Diego, California - Pharmaceutical industry decision-makers, scientists, researchers, technology developers and investors will gather in one location at GTC’s Biomarker Summit 2012, March 15-16 in San Diego, CA - GTCbio.com
GTCbio Announces Biomarker Summit 2012 - March 15-16 in San Diego, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2011/12/30 - Pharmaceutical industry decision-makers, scientists, researchers, technology developers and investors will gather in one location at GTC’s Biomarker Summit 2012, March 15-16 in San Diego, CA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Creating a unique gathering place for the pharmaceutical industry, GTC is pleased to announce the Biomarker Summit 2012 to be held on March 15-16, 2012 at the Paradise Point Resort in San Diego. The Summit will be the first of its kind to bring together biomarker development, diagnostics, oncology and business interests.

Gaining cutting edge insight and perspective into the latest science, research and business applications and opportunities of biomarkers, delegates will not only learn but share their perspectives at this interactive event while taking advantage of networking opportunities.

Broken into four tracks, the Summit will include the 6th Biomarker Development Conference, 4th Oncology Biomarker Conference, Biomarkers & Diagnostics Conference and Biomarker Partnering & Deal-Making Conference.

Offering delegates the choice to attend one track of the event or portions of all tracks allows attendees to hear from experts presenting their latest findings while maximizing the use of their time. It is truly like attending four separate events at once.

The 6th Biomarker Development Conference track will include discussion on issues including, next generation sequencing, personalized medicine, shortening development times, validation of preclinical to clinical studies, biomarkers in clinical trials, novel technologies and analytics.

The 4th Oncology Biomarker Conference track will discuss challenges in clinical translation in oncology biomarkers, advancements in prognostic markers, early disease diagnosis, personalized oncology care, emerging technologies and development of targeted oncology biomarkers.

Biomarkers & Diagnostics Conference includes personalized medicine, next generation sequencing, patient selection in diagnostic clinical trials, novel approaches and technologies, companion diagnostics, circulating biomarkers, and statistical analysis of new biomarkers.

Finally, the Biomarker Partnering & Deal Making Conference track covers the business aspects of the biomarker industry by discussing biomarker investments in the current market, co-diagnostics partnering models, investor perspectives, strategic direction for partnering, novel technology developers, intellectual property rights concerning biomarkers and diagnostic reimbursements.

For additional details regarding the Biomarker Summit 2012, please visit gtcbio.com/BiomarkerSummit2012 or call.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GTCbio Announces Biomarker Summit 2012 - March 15-16 in San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  Rapid Recovery





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)